Immunogen (NASDAQ:IMGN) reported its Q3 earnings results on Friday, November 4, 2022 at 06:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Immunogen missed estimated earnings by 24.0%, reporting an EPS of $-0.31 versus an estimate of $-0.25.
Revenue was up $6.17 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.03 which was followed by a 9.71% drop in the share price the next day.
Here’s a look at Immunogen’s past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.21 | -1.71 | -0.18 |
| EPS Actual | -0.24 | -0.10 | -0.17 | -0.18 |
| Revenue Estimate | 16.18M | 21.47M | 25.65M | 19.03M |
| Revenue Actual | 14.16M | 38.08M | 27.99M | 9.21M |
To track all earnings releases for Immunogen visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
